Creative Medical Technology Holdings Announces Superior Immune Modulatory of AmnioStem Stem Cells Compared … – PR Newswire (press release)
|
Creative Medical Technology Holdings Announces Superior Immune Modulatory of AmnioStem Stem Cells Compared …
PR Newswire (press release) PHOENIX, April 4, 2018 /PRNewswire/ — Creative Medical Technology Holdings (OTCQB: CELZ) announced today new data demonstrating superior immune modulatory ability of its AmnioStem™ stem cell product when compared head-to-head with bone marrow … |
